Of particular note, this effect was larger in patients with BRAF-mutated melanoma, accounting for ca 40% of all MM, which has a more aggressive phenotype, with distinct immune interactions, propensity for haematogenous spread and the development of brain metastases [114]. This evidence concerns the gene BRAF and melanoma.